Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3739985015 | Erythromycin and isotretinoin only product in cutaneous dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3739986019 | Product containing only erythromycin and isotretinoin in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Erythromycin and isotretinoin only product in cutaneous dose form | a pour principe actif (attribut) | Erythromycin (substance) | true | Inferred relationship | Some | 1 | |
| Erythromycin and isotretinoin only product in cutaneous dose form | est un(e) (attribut) | Erythromycin- and isotretinoin-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
| Erythromycin and isotretinoin only product in cutaneous dose form | a une forme pharmaceutique (attribut) | forme cutanée | true | Inferred relationship | Some | ||
| Erythromycin and isotretinoin only product in cutaneous dose form | est un(e) (attribut) | Erythromycin and isotretinoin only product | true | Inferred relationship | Some | ||
| Erythromycin and isotretinoin only product in cutaneous dose form | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Erythromycin and isotretinoin only product in cutaneous dose form | a pour principe actif (attribut) | Isotretinoin (substance) | true | Inferred relationship | Some | 2 | |
| Erythromycin and isotretinoin only product in cutaneous dose form | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) | est un(e) (attribut) | True | Erythromycin and isotretinoin only product in cutaneous dose form | Inferred relationship | Some |
This concept is not in any reference sets